RxDoctor Payments Data

William Sudholt, DO

Internal Medicine · Blue Springs, MONPI 1164486254

Payments from drug & device makers

$257in general payments, 2019–2025

Across 10 payments — averaging $25.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$125
  • Novartis$32
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$31
  • Hydrofera LLC$27
  • Lifenet Health$24
  • Johnson & Johnson$18

What the payments were for

  • Food & beverage$257100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$257 in reported general payments places this provider in the 55th percentile of 2,097 internal medicine providers in Missouri.

See all internal medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$155,330
Medicare patients
446
Services billed
1,688

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban648$170,799
JardianceEmpagliflozin143$41,691
MyrbetriqMirabegron138$36,334
XareltoRivaroxaban135$30,108
GlatopaGlatiramer Acetate18$27,498
EntrestoSacubitril/Valsartan97$25,431
OzempicSemaglutide12$12,267
CreonLipase/Protease/Amylase15$8,774
JanuviaSitagliptin Phosphate32$8,451
GemtesaVibegron19$8,298
Atorvastatin Calcium731$7,265
SantylCollagenase Clostridium Hist.13$6,984
Breo ElliptaFluticasone/Vilanterol16$6,917
Potassium Chloride349$6,783
Levothyroxine Sodium760$6,619

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$18$30,108135 claims
NovartisEntresto$32$25,43197 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,097 internal medicine providers in Missouri.

Other internal medicine in Blue Springs

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →